Integrated Continuous Glucose Monitoring Implementation and Connectivity: Best Practices, Featuring a Powered by Patients™ Interview (Pharmacy Technician Credit)

This activity was originally broadcast during the PTCE Diabetes Day of Education on May 21, 2024.

This activity includes a Powered by Patients™ interview.

Program Description

Many integrated continuous glucose monitoring (iCGM) devices now exist that improve the management of diabetes, with constant advancements in technology, including connectivity with insulin pumps, pens, and mobile applications. Continuous ketone monitoring (CKM) devices can be used in addition to CGM devices in the management of diabetes and prevention of diabetic ketoacidosis. Even though insurance coverage of CGM has improved, many people living with diabetes who may benefit from these technologies have not obtained them. Education from this session will allow pharmacists and pharmacy technicians to better identify optimal candidates for these devices and assist people living with diabetes using or considering these technologies through training and recommendations. This session will elaborate upon the important role of iCGM, with a focus on connected devices and CKM in the management of diabetes, as well as considerations for people living with diabetes who may benefit from both devices. As part of PTCE’s Diabetes Day of Education, this panel discussion, which includes a Powered by Patients™ interview, will delve into people living with diabetes who will benefit from iCGM and CKM devices and available standards or data surrounding these devices.

Target Audience: Pharmacy technicians

Type of Activity: Knowledge
Release date: June 13, 2024
Expiration date: June 13, 2025
Learner level: Intermediate
Time to complete activity: 1.5 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Express how integrated continuous glucose monitoring (iCGM) devices integrate with connected devices
• Recognize optimal candidates for iCGM and connected devices
• State the use of novel continuous ketone monitoring (CKM) devices in the management of diabetes
• Articulate supporting information for the integration of CKM devices into diabetes standards of care and the people living with diabetes who will benefit from CKM

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-24-185-H01-T. The activity is available for CE credit through June 13, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Diana Isaacs, PharmD, has the following relevant financial relationships with commercial interests to disclose:​

Consultant: LifeScan​

Speaker Bureau: Insulet Corporation, Dexcom, Abbott, Novo Nordisk, Lilly, MannKind Corporation, Sanofi​

Susan Cornell, PharmD has the following relevant financial relationships with commercial interests to disclose:

Advisory Board: Novo Nordisk, Inc​

Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES has the following relevant financial relationships with commercial interests to disclose:

Speaker Bureau: Abbott Diabetes Care, Insulet Corporation, Xeris Pharmaceuticals​

Robert Nichols, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; Chloe Taccetta, and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms